- Home
- AQST vs RMR Comparison
AQST vs RMR Comparison
Compare AQST & RMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- RMR
- Stock Information
- Founded
- AQST 2004
- RMR 1986
- Country
- AQST United States
- RMR United States
- Employees
- AQST N/A
- RMR N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- RMR Professional Services
- Sector
- AQST Health Care
- RMR Consumer Discretionary
- Exchange
- AQST Nasdaq
- RMR Nasdaq
- Market Cap
- AQST 502.6M
- RMR 425.8M
- IPO Year
- AQST 2018
- RMR N/A
- Fundamental
- Price
- AQST $4.41
- RMR $22.19
- Analyst Decision
- AQST Strong Buy
- RMR Buy
- Analyst Count
- AQST 7
- RMR 2
- Target Price
- AQST $9.43
- RMR $32.00
- AVG Volume (30 Days)
- AQST 1.7M
- RMR 85.5K
- Earning Date
- AQST 11-04-2024
- RMR 11-11-2024
- Dividend Yield
- AQST N/A
- RMR 8.11%
- EPS Growth
- AQST N/A
- RMR N/A
- EPS
- AQST N/A
- RMR 1.38
- Revenue
- AQST $58,900,000.00
- RMR $196,924,000.00
- Revenue This Year
- AQST $18.45
- RMR $287.63
- Revenue Next Year
- AQST N/A
- RMR $0.06
- P/E Ratio
- AQST N/A
- RMR $16.08
- Revenue Growth
- AQST 22.56
- RMR N/A
- 52 Week Low
- AQST $1.69
- RMR $22.01
- 52 Week High
- AQST $6.23
- RMR $28.82
- Technical
- Relative Strength Index (RSI)
- AQST 37.69
- RMR 25.65
- Support Level
- AQST $4.62
- RMR $22.35
- Resistance Level
- AQST $5.59
- RMR $24.84
- Average True Range (ATR)
- AQST 0.37
- RMR 0.61
- MACD
- AQST -0.11
- RMR -0.20
- Stochastic Oscillator
- AQST 2.54
- RMR 2.93
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.
About RMR The RMR Group Inc.
The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company that invests in real estate and manages real estate-related businesses. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company's operating segment is RMR LLC and All Other Operations. The RMR Group derives its revenue from providing business and property management services as well as advisory and other services.